Ovarian Cancer in Infertile Females in the Czech Republic: part I
Authors:
as. MUDr. Robert Hudeček 1; prof. MUDr. Pavel Ventruba; DrSc. 1; MUDr. Martin Huser 1; MUDr. Eva Račanská 1; MUDr. Radka Vavrušová 1; doc. RNDr. Jana Šarmanová; CSc. 2; MUDr. Jan Novák 3; MUDr. A. Koukalová 3
Authors place of work:
Gynekologicko-porodnická klinika LF MU a FN Brno
1; Fakulta elektrotechniky a informatiky, VŠB, Ostrava
2; Národní onkologický registr, MOÚ Brno
3
Published in the journal:
Prakt Gyn 2006; 10(3): 100-104
Summary
The study analyzes the complexity of infertility and impaired fertility treatment in relation to the risk of ovarian cancer in the Czech Republic and abroad. The key role of in vitro fertilization as an infertility treatment is pointed out as well as etiological factors increasing the risk of ovarian cancer. Basic hypotheses for effects of medicaments treating infertility in relation to the etiology of ovarian tumours are summarized in this study and all the findings are documented in a list of contemporary and prior international studies. The authors present prospective resources of relevant information on assisted reproduction, which are subjects to further analyses.
Key words:
infertility – assisted reproduction – ovarian cancer
Zdroje
1. Aboulghar MA, Mansour RT. Ovarian hyperstimularion syndrome: classification and critical analysis of preventive measures. Hum Reprod Update 2003; 9: 275-289.
2. Aleksander I, Morton H. An introduction to Neural Computing. London: Chapman Hall 1993.
3. Balasch J, Barri NP. Follicular stimulation and ovarian cancer? Hum Reprod 1993; 8: 990-996.
4. Beerendonk CC, Van Dop PA, Braat DD, Mercus JM. Ovarian hyperstimularion syndrome: facts and fallacies. Obstet Gynecol Surv 1998; 53: 439-449.
5. Bertone-Johnson ER. Epidemiology of ovarian cancer: a status report. Lancet 2005; 365 (8): 101-102.
6. Brinsden PR, Rainsbury PA. A textbook of in vitro fertilisation and assisded reproduction. Lancaster: The Parthenon Publishing Group 1992: 451.
7. Brinton LA, Lambm EJ, Moghissi KS et al. Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol 2004; 103(6): 1194-1203.
8. Brinton LA, Moghissi KS, Scoccia B et al. Ovulation induction and cancer risk. Fertil Steril 2005; 83(2): 261-74, 525-526.
9. Bristow RE, Beth ZK. Ovulation induction, infertility and ovarian cancer risk. Fertil Steril 1996; 66: 499-507.
10. Bristow RE, Karlan BY. The risk of ovarian cancer after treatment of infertility Curr Opin Obstet Gynecol 1996; 8: 32-37.
11. Burcin B, Caithamlová E, Kučera T et al. Demografické souvislosti asistované reprodukce v České republice a na Slovensku. Prakt Gyn 2005; 5: 11-12.
12. Cohen J, Forman R, Harlap S et al. IFFS expert group report on the Whittemore study related to the risk of ovarian cancer associated with use of fertility agents. Hum Reprod 1993; 8(7): 996-999.
13. Colaborative Report on In Vitro Fertilization. Preliminary Data for 1995. J Assist Reprod Genet 1995; 12: 251S-265S.
14. Crha I, Ventruba P. GnRH Analogs in the Treatment od IVF Patients with Endometriosis - Anticardiolipin and Antihiston Profiles. In: Abstrakt book of IXth World Congress on In Vitro Fertilisation and Assisted Reproduction. Bologna: Monduzzi Editore S.p.A: 677-681.
15. Cramer DW, Welch WR. Determinant sof ovaria cancer risk. Inferences regarding pathogenesis. J Nati Cancor Indy 1983; 71: 717-721.
16. Cramer DW, Liberman RF, Hornstein MD. Basal hormone levels in women who use acetaminofen pro menstrual pain. Fertil Steril 1998; 70: 731-733.
17. Delvigne A, Rozenberg S. Preventive attitude of physicians to avoid OHSS in IVF patients Hum Reprod 1993; 16: 2491-2495.
18. Delvigne A, Dubois M, Battheu B et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. II. Multiple discriminant analysis for risk prediction. Hum Reprod 2001; 18: 1361-1366.
19. Delvigne A, Vandromme J, Barlow P et al. Are there predictive criteria of complicated ovarian hyperstimulation in IVF? Hum Reprod 1991; 6: 959-962.
20. De Mouzon J, Bachelot A, Spira A. Establishing a national in vitro fertilisation registry: methodological problems and analysis of success rates. Statistics in medicine 1993; 12: 39-50.
21. Dor J, Lerner-Geva L, Rabinovici J et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 2002; 77(2): 324-327.
22. Doyle P, Maconochie N, Beral V et al. Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod 2002; 17(8): 2209-2213.
23. Elchalal U, Schenker JG. The pathophysiology of ovarian hypersumilation syndrome – views and ideas. Hum Reprod 1997; 12: 1129-1137.
24. Folsom AR, Sellers TA, Kaye SA et al. Infertility linket to brest cancor. BMJ 1993; 17(306): 1065.
25. Güverin HA, Demiroz G, Ilter N. Learning Differential Diagnosis of Erythemato Squamous Diseases Using Voting Feature Intervals. Artificial Intelligence in Medicina 1998.
26. Hardiman P, Nieto JJ, MacLaren BA. Infertility and ovarian cancor. Gynecol Oncol 2000; 76: 1-2.
27. Hudeček R. Závěrečná zpráva Grantu IGA MZ ČR 4696-3/2001: Analýza faktorů ovlivňujících výsledky asistované reprodukce pomocí systému pro dolování znalostí z dat SHLUK a neuronové sítě NEUL 3.
28. Hudeček R, Ventruba P, Šarman Z et al. Data mining in assisted reproduction using methods for data analysis SHLUK and artificial neural network NEUL 3. Asist. Reprod 2000; 1: 10-11.
29. Hudeček R, Ventruba P, Crha I et al. Analysis of Factors with Influence on Assisted Reproduction Outcome using System for Data Mining SHLUK. Čes Gynek 2001; 66: 270-276.
30. Hudeček R, Huser M, Ventruba P, Šarmanová J. Risk factors of ovarian hyperstimulation syndrome development in asisted reproduction. Prakt Gyn 2004; 4: 6-12.
31. Hudeček R, Ventruba P, Petrenko M. Počítačový software v gynekologii a porodnictví. Prakt Gynekol 1998; 1: 66-69.
32. International Working Group for Registers on Assisted Reproduction: World Colaborative Report on In Vitro Fertilization. Preliminary Data for 1996. J Assist Reprod Genet 1997; 14: 251S-265S.
33. International Federation of Fertility Societies International Conference. IFFS Surveillance 98. Fertil Steril 1999; 71(5 Suppl 2): 1S-34S.
34. Kashyap S, Moher D, Fung MF, Rosenwaks Z. Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis. Obstet Gynecol 2004; 103(4): 785-794.
35. Kaufman L, Rousseew PJ. Finding Groups in Data: an Introduction to Cluster Analysis. John Wiley & Sons 1990.
36. Kaufmann SJ, Eastaugh JL, Snowden S et al. The application of neural networks in predicting the outcome of in vitro fertilisation. Human reproduction 1997; 12(7): 1454-1457.
37. Kempers RD, Cohen J, Haney AF, Yonga JB. Fertility and reproductive medicine. Amsterdam: Excepta medica 1998.
38. Kohonen T. Self-Organizing Maps. Berlin: Springer Verlag 1995.
39. Lukasová A, Šarmanová J. Metody shlukové analýzy. Praha: SNTL 1985.
40. Mardešić T. Hyperstimulační syndrom - klasifikace, patofyziologie, prevence a léčba. Čs Gynek 1993; 58: 23-27.
41. Mařík V, Štěpánková O, Lažanský J. Umělá inteligence 1. Praha: Academia 1993.
42. Mařík V, Štěpánková O, Lažanský J. Umělá inteligence 2. Praha: Academia 1993.
43. Matzuk MM, Finegold MJ, Su JG. Alpha inhibin is a tumor-suppresor gene with gonadal specificity in mice. Nature 1992; 360: 313-319.
44. Michalski R, Kaufmann K. Data Mining and Knowledge Discovery: A Review of Issues and a Multistrategy Approach. In: Machine Learning and Data Mining: Methods and Applications. John Wiley & Sons Ltd 1997.
45. Navot D, Bergh PA, Laufner N. Ovarian hypersumilation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1993; 58: 249-261.
46. Navot D, Relou A, Birkenfeld A. Risc factors and prognostic variables in the ovarian hypersumilation syndrome. Am J Obstet Gynecol 1988; 159: 210-215.
47. Novák M, Kufudaki O. Umělé neuronové sítě - teorie a aplikace. Praha: C.H. Beck 1998.
48. Novák M, Faber J, Kufudaki O. Neuronové sítě a informační systémy živých organismů. Praha: Grada 1993.
49. Ness RB, Cramer DW, Goodman MT et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 2002; 155(3): 217-224.
50. Pettersson F, Fotkou S, Einhorn N. Kohort study of the long term effect of irradiation for carcinoma of sterine cervix. Acta Radiol Oncol 1985; 24: 145-151.
51. Robová H, Rob L, Pluta M, Kačírek J. Zhoubné nádory ovaria, Moderní gynekologie 2000; 9(4): 679-693.
52. Rossing MA, Dalling JR, Weis NS. Ovaria tumors in a cohort of infertile women. N Engl J Med 1994; 331: 771-776.
53. Rossing MA, Tang MT, Flagg EW et al. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs. Am J Epidemiol 2004; 160(11): 1070-1078.
54. Shusman A, Paltiel O, Iscovitch J. Human menopausal gonadothropin and the risk of epithelial ovarian cancer. Fertil Steril 1996; 65: 13-18.
55. Schildkraut JM, Schwingl PJ, Bastos E. Epithelial ovarian cancer risk amongh women with polycystic ovary syndrome. Obstet Gynekol 1996; 88: 554-559.
56. Šarmanová J. Systém pro automatizované získávání znalostí. In: Sb. Mezinárodní vědecká konference VŠB' 95, sekce Informatika. Ostrava 1995: 463.
57. Šarmanová J. Systém generování hypotéz nad mnohorozměrnými daty. [Habilitační práce] Ostrava.
58. Šarmanová J. Dolování znalostí z lékařských dat. Medsoft 1999; 1: 39-41.
59. Vercellini P, Parazzini F, Bolis G. Endometriosis and ovarian cencer. Am J Obstet Gynecol 1993; 169: 181-182.
60. Ventruba P, Višňová H, Hudeček R. Where is the aim of ART in Czech Republic? National register of ART 1993-1996. Prakt Gyn 1997; 5: 20-26.
61. Ventruba P, Mardesic T, Pilka L et al. Register of Assisted Reproduction: Results and analysis of complicationes. Čes Gynek 1998; 63: 39-41.
62. Ventruba P, Višňová H, Hudeček R, Lokajová J. 10 years od National Register of sassisted reproduction in Czech Republic. Asist Reprod 2000; 10: 5-6.
63. Ventruba P, Višňová H, Hudeček R. Where is the aim of ART in Czech Republic? National register of ART 1993-1996. Prakt Gyn 1997; 5: 20-26.
64. Ventruba P, Mardesic T, Pilka L et al. Register of Assisted Reproduction: Results and analysis of complicationes. Čes Gynek 1998; 63: 39-41.
65. Ventruba P, Višňová H, Hudeček R, Lokajová J. 10 years od National Register of sassisted reproduction in Czech Republic. Asist Reprod 2000; 10: 5-6.
66. Ventruba P, Višňová H, Hudeček R. Kam směřuje vývoj asistované reprodukce v České republice? Národní registr ART 1993-1996. Prakt Gyn 1997: 1(5): 20.
67. Ventruba P, Mardesic T, Pilka L. Registr asistované reprodukce: výsledky a analýza komplikací. Čes Gynek 1998; 63: 39-41.
68. Ventruba P, Višňová H, Hudeček R, Lokajová J. 10 let národního registu asistované reprodukce v ČR. Asistovaná reprodukce 2000; 10(1): 5-6.
69. Ventruba P. Klinické metody asistované reprodukce. Doktorská disertační práce. 3. LF UK Praha 1992: 324.
70. Ventruba P, Veselý J, Rejdová I et al. Early Diagnosis and Outcome Prediction of Pregnancy Following In Vitro Fertilisation. Scripta medica Fac med Brun 1992; 65: 323-332.
71. Ventruba P. Závěrečná zpráva Grantu IGA MZ ČR 0388-2/1991: Klinická realizace nových metod asistované reprodukce.
72. Ventruba P. Závěrečná zpráva Grantu IGA MZ ČR 1770-2/1993: Asistovaná reprodukce II. Realizace metod v oblasti imunol., mikrobiol., kryokonzervace.
73. Ventruba P. Závěrečná zpráva Grantu IGA MZ ČR 1820-2/1994: Optimalizace in vitro fertilizace kokultivací embrií s lidskými tubárními epiteliemi.
74. Ventruba P. Závěrečná zpráva Grantu IGA MZ ČR 1821-2/1994: Asistovaná reprodukce - mikromanipulace v oblasti zona pellucida zvyšující úspěšnost oplození.
75. Ventruba P. Závěrečná zpráva Grantu IGA MZ ČR 2703-2/1995: Vztah mezi buňkami kumulus oophorus a časným embryem při kultivaci in vitro.
76. Ventruba P. Závěrečná zpráva Grantu IGA MZ ČR 2705-2/1995: Lokální imunologické faktory ovlivňující tvorbu adhezí.
77. Ventruba P, Višňová H, Hudeček R. Kam směřuje vývoj asistované reprodukce v České republice? Národní registr ART 1993–1996. Prakt Gyn 1997; 1(5): 20.
78. Ventruba P, Višňová H, Hudeček R. Asistované reprodukce v Evropě v roce 1999. Parametry kvality a výsledky registru ESHRE. Reprod Medic 2002; 1: 10.
79. Ventruba P, Veselý J, Unzeitg V et al. Klinické využití osobního počítače v léčbě neplodnosti. Čes gynekol 1991; 1: 194.
80. Venn A, Healy D, McLachlan R. Cancer risks associated with the diagnosis of infertility. Best Pract Res Clin Obstet Gynaecol 2003; 17(2): 343-367.
81. Whittemore SA. Fertility drugs and risk of ovarian cancor. Hum Reprod 1993; 8(7): 999-1000.
82. Whittemore SA. The Collaborative Ovaria Cancor Group: Characteristics relating to ovaria cancer risk: collabborative analysis of 12 US case-control studies. II Invasive epithelial ovaria cancor in white women. Am J Epidemiol 1992; 136: 1184–1203.
83. Zytkow JM, Rauch J. Principles of Data Mining and Knowledge Discovery, September 1999. Third European Conference, PKDD'99, Prague, Czech Republic.
Štítky
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicineČlánok vyšiel v časopise
Practical Gynecology
2006 Číslo 3
Najčítanejšie v tomto čísle
- Ureaplasma Urealyticum as a Cause of Chronic Vaginal Discharge
- New gyneco-urological and sexological implications of the female prostate and female prostate specific antigen
- The possibility of donated gametes or embryos usage in infertility treatment
- The profile of tibolon with regard to breast safety in long-term therapy